The Single Biggest Opportunity to Buy Texas Instruments Before July 22 Earnings

Texas Instruments is set to report Q2 2026 results on July 22, with management guidance implying a step-change quarter. The article notes an improving free-cash-flow inflection and end-market acceleration (industrial and data center) into the release. Overall setup is viewed as favorable heading into earnings, though no specific figures are cited.

Analysis

TXN’s setup matters less as a one-quarter earnings beat and more as a proof point that the analog upcycle is becoming self-funding. If free cash flow is inflecting while industrial and data-center demand are both still improving, the market can start underwriting a higher quality of earnings: less capital drag, better conversion, and a cleaner path back to peak-cycle margins. That is usually what drives multiple expansion in analog, not the top-line print itself.

The relative-value implication is more interesting than the outright long. A constructive TXN print should lift the entire analog bucket, but the second-order benefit accrues most to names with worse balance-sheet optics or more questionable FCF durability, because TXN can validate the cycle without requiring aggressive inventory rebuilds. If the quarter confirms real end-demand rather than channel restocking, it also helps distributors and industrial suppliers; if not, the read-through should fade quickly.

The key risk is that the market is already leaning into a positive guide, so the first move may be in the stock rather than the business. For the next 1-3 months, the thesis only works if management converts demand momentum into a better capex/FCF narrative; over 6-18 months, the real upside is a re-rating tied to lower capital intensity. What would break it is any indication that the inflection is inventory-driven, or that data-center strength is too narrow to offset weakness elsewhere in the mix.

Key Decisions for Investors

• Long TXN into the print or on any post-earnings pullback; base case is a 5-10% rerate if FCF guidance and margin cadence confirm the inflection, with downside limited if the quarter is merely in-line but the cash profile improves.
• Pair trade: long TXN / short MCHP over the next 1-3 months to express quality-vs-cyclical execution; TXN’s cleaner FCF conversion should outperform if the analog recovery is real, while MCHP is more exposed to a weaker second-order inventory unwind.
• Use a defined-risk bullish options structure on TXN only if implied move is not already rich: buy an August or September call spread to capture a post-earnings rerating without paying full upside for a single-quarter beat.
• Set a watch item on TXN commentary around capex and backlog quality; if management implies the improvement is mostly restocking, take profits quickly because the stock can retrace once the market shifts from 'cycle bottom' to 'temporary bounce.'
• If TXN gaps up hard on the release but fails to hold gains into the next 1-2 sessions, fade strength rather than chase; that would signal the street already owned the inflection and the forward multiple is the real debate.